Literature DB >> 22797149

The 2012 ESC Guidelines on Heart Failure.

Jennifer Taylor.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22797149     DOI: 10.1093/eurheartj/ehs138

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  5 in total

1.  Effect of percutaneous renal sympathetic nerve radiofrequency ablation in patients with severe heart failure.

Authors:  Qiming Dai; Jing Lu; Benwen Wang; Genshan Ma
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Ivabradine therapy to unmask heart rate-independent effects of β-blockers on pulse wave reflections.

Authors:  Ulrich Fischer-Rasokat; Jörg Honold; Denise Lochmann; Christoph Liebetrau; Jürgen Leick; Christian Hamm; Stephan Fichtlscherer; Helge Möllmann; Ioakim Spyridopoulos
Journal:  Clin Res Cardiol       Date:  2014-02-18       Impact factor: 5.460

Review 3.  Cardiac contractility modulation: a novel approach for the treatment of heart failure.

Authors:  Freddy Abi-Samra; David Gutterman
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

4.  The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.

Authors:  Basile Gravez; Antoine Tarjus; Ruben Jimenez-Canino; Soumaya El Moghrabi; Smail Messaoudi; Diego Alvarez de la Rosa; Frederic Jaisser
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

5.  ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failure.

Authors:  Jin Huang; Chenze Li; Ying Song; Xiaohan Fan; Ling You; Lun Tan; Lei Xiao; Qing Li; Guoran Ruan; Senlin Hu; Wei Cui; Zongzhe Li; Li Ni; Chen Chen; Anthony Yiu-Ho Woo; Rui-Ping Xiao; Dao Wen Wang
Journal:  Cell Discov       Date:  2018-10-23       Impact factor: 10.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.